Tag Archives: Off-Label Marketing

Problems with Gabapentin Misuse are a Sign of Improper Prescribing: Report

September 13, 2022 By: Martha Garcia

Gabapentin problems with misuse and abuse are increasing, with overdoses often involving the use of opioid medications as well, researchers found.
Bayer Whistleblower Settlement Over Trasylol, Avelox and Baycol Results in $40 Million Payment

September 07, 2022 By: Irvin Jackson

Agreement comes following a whistleblower lawsuit filed by a former marketing employee, who will receive $11 million award for uncovering the misconduct and pursuing the Bayer settlement through the False Claims Act.
Whistleblower Lawsuit Over AstraZeneca Off-Label Marketing Ends in $2.4M Verdict

June 24, 2021 By: Irvin Jackson
Most Doctors Say FDA Should Continue To Restrict Off-Label Drug Marketing: Study

January 29, 2019 By: Irvin Jackson
Antidepressant Prescriptions For Non-Approved Indications Often Not Supported By Science: Study

February 28, 2017 By: Irvin Jackson
FDA Issues New Draft Guidance On Medical Product Communications

January 20, 2017 By: Irvin Jackson
Abilify Settlement to Result in $19.5 Payment by Bristol-Myers Squibb

December 12, 2016 By: Irvin Jackson
FDA Weighs Risks, Benefits, Of Relaxing Off-Label Marketing Restrictions

November 11, 2016 By: Irvin Jackson
Lawmakers’ Move To Allow off-Label Marketing Opposed By Public Citizen

June 09, 2016 By: Irvin Jackson
Drug Company Settlements On Decline As Enforcement Wanes: Public Citizen Report

April 14, 2016 By: Irvin Jackson

Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (Posted 5 days ago)

Illinois man has filed an Oxbryta lawsuit, indicating that the recalled sickle cell disease treatment caused a stroke shortly before Pfizer pulled the drug from the market.

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted 6 days ago)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 9 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Tag Archives: Off-Label Marketing

Problems with Gabapentin Misuse are a Sign of Improper Prescribing: Report

Bayer Whistleblower Settlement Over Trasylol, Avelox and Baycol Results in $40 Million Payment

Whistleblower Lawsuit Over AstraZeneca Off-Label Marketing Ends in $2.4M Verdict

Most Doctors Say FDA Should Continue To Restrict Off-Label Drug Marketing: Study

Antidepressant Prescriptions For Non-Approved Indications Often Not Supported By Science: Study

FDA Issues New Draft Guidance On Medical Product Communications

Abilify Settlement to Result in $19.5 Payment by Bristol-Myers Squibb

FDA Weighs Risks, Benefits, Of Relaxing Off-Label Marketing Restrictions

Lawmakers’ Move To Allow off-Label Marketing Opposed By Public Citizen

Drug Company Settlements On Decline As Enforcement Wanes: Public Citizen Report

More Top Stories

Review A Case